Transmedics Group Inc expected to post a loss of 16 cents a share - Earnings Preview

TransMedics

04/11/2023 03:01

* Transmedics Group Inc  TMDX.OQ   TMDX.O  is expected
to show a
rise in quarterly revenue when it reports  results 
    * The Andover Massachusetts-based  company is expected to
report 
a 91.5% increase in revenue to $49.188 million from $25.68
million a year ago, according to the mean estimate from 5
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Transmedics Group
Inc is
for a loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Transmedics
Group
Inc is $95.5​, above​ its last closing price of $42.62. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.11       -0.13      -0.03     Beat    76.9
 Mar. 31 2023  -0.21       -0.25      -0.08     Beat    67.5
 Dec. 31 2022  -0.30       -0.30      -0.21     Beat    30​
 Sep. 30 2022  -0.43       -0.41      -0.25     Beat    39.3
 ​​Jun.        -0.35       -0.35      -0.41     Missed  -17.8
 30 2022                                                
 Mar. 31 2022  -0.39       -0.38      -0.38     Met     0​
 Dec. 31 2021  -0.43       -0.42      -0.46     Missed  -8.5
 Sep. 30 2021  -0.36       -0.36      -0.47     Missed  -32
 This summary was machine generated November 4 at 03:01 GMT.  All
figures in US dollars  unless otherwise stated